From the National Center for Advancing Translational Sciences
From the National Institutes of Health
Drug Discovery in ALS: Opportunities and Challenges
Sunday, March 04, 2012 -
Wednesday, March 07, 2012
Washington , D.C.
The goals of the workshop are:  To bring clinical and scientific leaders from academia and industry together to focus on drug discovery for ALS.  To enable discussion and new project ideas to evolve from the interaction of researchers with different expertise in ALS and related fields.  To bring young researchers at an early stage of their careers to a stimulating and educational forum enabling them to interact and learn from their peers.  To discuss three key areas that impact ALS Drug Discovery and related fields: A) Academic and Industry Partnerships, B) New Opportunities for Biomarker studies in ALS, and C) Clinical Trials Networks to enhance patient enrollment and standardization of trials between sites.
Contact: Dr. Margaret Sutherland, 301-496-5680
National Institute of Neurological Disorders and Stroke
Office of Rare Diseases Research